Results 11 to 20 of about 373,288 (339)
Journal of Translational Medicine, 2020 Background Elevated lipoprotein(a) [Lp(a)] and fibrinogen (Fib) are both associated with coronary artery disease (CAD). The atherogenicity of Lp(a) can be partly due to the potentially antifibrinolytic categories. We hypothesize that patients with higher
Yan Zhang +15 more
doaj +1 more source
Scientific Reports, 2023 Diabetes, hypertension, and dyslipidemia are obesity-related comorbidities that contribute to the development of cardiovascular disease, one of the leading causes of death.
Tomoko Yamada +4 more
semanticscholar +1 more source
Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus
Clinical Rheumatology, 2023 Introduction Disturbed lipid metabolism was observed in systemic lupus erythematosus (SLE) patients. This study aimed to evaluate the relationships between dyslipidemia and visceral organ involvement, disease severity, inflammatory factors, and drug ...
Saisai Huang +5 more
semanticscholar +1 more source
Diabetes Therapy, 2016 Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular ...
Schofield, Jonathan D +4 more
openaire +3 more sources
Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Nutrients, 2023 Dyslipidemia is a multifaceted condition with various genetic and environmental factors contributing to its pathogenesis. Further, this condition represents an important risk factor for its related sequalae including cardiovascular diseases (CVD) such as
Brandon Flaig +4 more
semanticscholar +1 more source
A Modern Approach to Dyslipidemia
Endocrine reviews, 2021 Lipid disorders involving derangements in serum cholesterol, triglycerides, or both are commonly encountered in clinical practice and often have implications for cardiovascular risk and overall health.
A. Berberich, R. Hegele
semanticscholar +1 more source
New insight into dyslipidemia‐induced cellular senescence in atherosclerosis
Biological Reviews of The Cambridge Philosophical Society, 2022 Atherosclerosis, characterized by lipid‐rich plaques in the arterial wall, is an age‐related disorder and a leading cause of mortality worldwide. However, the specific mechanisms remain complex.
Qun-yan Xiang +5 more
semanticscholar +1 more source
OBESITY AND DYSLIPIDEMIA IN CHILDREN WITH CHRONIC HEPATITIS [PDF]
Romanian Journal of Pediatrics, 2016 Chronic hepatitis association with various types of dyslipidemia is a reality not only for the obese pediatric patient, in which we expect to find hypercholesterolemia and / or hypertriglyceridemias, but also for normal weight children with hepatitis ...
Alice N. Azoicai +7 more
doaj +1 more source
Antihypertensive drug class and dyslipidemia: risk association among Chinese patients with uncomplicated hypertension [PDF]
, 2008 Factors associated with dyslipidemia in Chinese patients with uncomplicated hypertension were investigated in 1,139 patients newly prescribed a single antihypertensive drug in the public primary healthcare setting in Hong Kong, where their fasting lipid ...
BL Kasiske +16 more
core +1 more source
Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment
European Journal of Case Reports in Internal Medicine, 2018 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are generally safe and well-tolerated drugs that are extensively used for the primary and secondary prevention of atherosclerotic cardiovascular events.
Zsófia Vesza +2 more
doaj +1 more source